AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Scientists review the present status of antileishmanial vaccines in a recent issue of Molecular and Cellular Biochemistry.
According to published research from India, "The term leishmaniasis refers collectively to various clinical syndromes that are caused by obligate intracellular protozoa of the genus Leishmania. Approximately 350 million people in eight countries are estimated to be threatened by the disease. The World Health Organization estimated that there are 12 million cases of all forms of leishmaniasis worldwide, with over 500,000 new cases of visceral disease occurring each year."
"Most of the drugs commonly used to treat different forms of leishmaniasis are toxic and have unacceptable side effects," said Monidipa Ghosh and Santu Bandyopadhyay at the Indian Institute of Chemical Biology. "Moreover, cases of drug resistant leishmaniasis are on the rise due to nonexistence of effective ...
Source: HighBeam Research, Present status of antileishmanial vaccines reviewed.